Potential market

SECTION I: The product

1a

The innovation potential of this product is related to:

  • Technology-driven innovation (under the influence of the development of science – the market is not ready for the product)
  • Market-driven innovation (as a result of market surveys, the market expects the product)
  • Replacement of existing product
  • Product related to cost reduction
  • Radical new product
  • Other, what…

The design has the purpose to realize a product intended for the field of medicine, more specifically it aims  to realize a cost reduction (health care expenditure) by the ASL.

1b

What added value for end-users does the product hold?
• higher quality
• Better technical characteristics
• Other …
Higher quality of health services and improving the effectiveness of treatment by the diabetes centres.

1c

What is the Unique Sales Proposition of the potential product?

The product interfaces directly with the business applications of the diabetes centres, have EuroTouch application. That’s why our product is a forced choice.

SECTION 2: The Market

2a

What is the target market for the product? Please describe the characteristics of your target market.

X  National

European

Global

The market range is made up of 20 Italian regions with the ability to install 20 licenses of the product and about 140 licenses to the management of diabetes centres.

2b

How the product is characterized from the following options? Number of companies producing similar products in the field.

• Base – applied by all companies in the industry

• Leading – applied by a single or limited number of competitive companies

• Key –at a development stage, but has already proven its potential

The product is of the Leading, or used by a limited number of economic subjects.

2c

What type of market demand will be satisfied?

• Existing demand – the market is already developed

• hidden (latent) demand – the market has yet to be developed

The market demand is growing, given the necessary reduction in costs and effectiveness of public health interventions required.

2d

What is the current stage of the product’s market life cycle?

• Implementation, implementation in production (leading to a radically new product offers)

• Growth (rapid spread within the industry or outside it)

• maturity (parameters of the technical characteristics of manufactured products reached their maximum, higher-grade products can be manufactured on the basis of technological substitution)

The product is still being implemented and could be placed on the market within 12 months.

2e

Strategic partnerships (existing or potential).
Potential Strategic Partnership consists of the company that EuroTouch application for the management of diabetic patients treated at the  diabetes centres and developers of BIMOD.

SECTION 3: The Competition

3a

What is the competition within your target market?
Currently there is no market-specific product, and thus no competition  between manufacturers.

3b

What competitive advantages will the introduction of the new product ensue?

• lower prices based on lower production costs

• product differentiation (uniqueness of the product proposal)

The development and implementation of the product as a result of the project has Bimod, the main objectives, to lower the cost of public health, now very high, and achieve greater planning on the use of funds  available, which are always decrease,  seen  also  waste  that  are  detected to date. Another considerable advantage is to obtain a real verification of the effectiveness of treatment implemented.

3c

Potential products relate to the following price range:

• High price range

• Average price range

• Low price range

The product of R & D within the range of specialized products and then be acquired at high cost.

3d

Potential products will be marketed:

• To regulated markets (e.g. heat supply, water supply, universal telecommunication services, agricultural products, fishing industry, architectural services)

• To markets operating on the principle of free negotiation between agents on the market

Markets that operate with the principles of free trade.

SECTION 4: Indicators

Estimated cost of the new products € 33.000 for license on average
Expected market volume (potential / maximum number of users) 28 license
Expected sales volume €980.000,00
Expected market share of the company (proportion between sales and total company sales in the relevant market)  25%

KEYWORDS QUANTITATIVE ASSESSMENT (0-5).

Added-value potential

1

2

x

4

5

Size of future market demand

1

2

3

x

5

Competitive positioning of the product

1

2

3

4

x

Bookmark the permalink. Follow any comments here with the RSS feed for this post. Post a comment or leave a trackback: Trackback URL.

Post a Comment

You must be logged in to post a comment.

Request a proposal

Valorisation Plan Authors

Related Documents

There in no related documents

Visit the other applications of the INTERVALUE Platform: R&D Repository | IP Agreements

© 2009-2010 INTERVALUE Project